HIGHLIGHTS
- who: Renata Faermann et al. from the Meirav Center for Women`s Health and High-Risk Clinic, Sheba Medical Center, Ramat Gan, Israel Tel Aviv University, Tel Aviv, Israel have published the research work: Ductal Carcinoma In Situ (DCIS) Diagnosed by MRI-Guided Biopsy among BRCA1/BRCA2 Mutation Carriers, in the Journal: ue020e Breast Journal of 27/Oct/2022
- what: The aim of this study was to assess the rate of detection over a 5-year period and the imaging features of All MRI-guided biopsies performed during the study period in the institution in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.